ÉϺ£-2020Äê7ÔÂ23ÈÕ-º²É­ÖÆÒ©½ñÈÕÐû²¼¾Í°¢ÃÀÌæÄáÓëÒ½¿âÒ©Òµ£¨EQRx£©¸æ¿¢Õ½ÂÔÏàÖúºÍÊÚȨЭÒé£¬£¬£¬£¬£¬£¬£¬Ò½¿âÒ©ÒµÊÇÒ»¼ÒÖÂÁ¦ÓÚ½µµÍÁ¢ÒìÒ©Îï¼ÛÇ®£¬£¬£¬£¬£¬£¬£¬ÒÔÔ츣»£»£»£»£»£»¼ÕߺÍÈ«Éç»áµÄÉúÎïÖÆÒ©¹«Ë¾¡£¡£¡£¡£¡£¡£Æ¾Ö¤Ð­ÒéÌõ¿î£¬£¬£¬£¬£¬£¬£¬Ò½¿âÒ©Òµ½«ÈÏÕæ´óÖлªÇøÓòÍâ°¢ÃÀÌæÄáµÄ¿ª·¢ÒÔ¼°ÉÌÒµ»¯£¬£¬£¬£¬£¬£¬£¬º²É­ÖÆÒ©½«¼ÌÐøÈÏÕæ´óÖлªÇø°¢ÃÀÌæÄáµÄ¿ª·¢ºÍÉÌÒµ»¯¡£¡£¡£¡£¡£¡£Ò½¿âÒ©ÒµºÍº²É­ÖÆÒ©½«ÅäºÏ¾ÙÐÐÈ«Çò¿ª·¢Ñо¿£¬£¬£¬£¬£¬£¬£¬ÒÔ½øÒ»²½À©´ó°¢ÃÀÌæÄá×÷Ϊµ¥Ò©ºÍÁªÊÊÓÃÒ©µÄÖÎÁÆDZÁ¦¡£¡£¡£¡£¡£¡£º²É­ÖÆÒ©½«»ñµÃÊ׸¶¿î¡¢×¢²áºÍÉÌÒµ»¯Àï³Ì±®¸¶¿îÒÔ¼°ÌØÐíȨʹÓ÷Ñ¡£¡£¡£¡£¡£¡£

¡°Ò½¿âÒ©Òµ¾ßÓÐÌìϼ¶µÄÁÙ´²ºÍ×¢²áÍŶÓ£¬£¬£¬£¬£¬£¬£¬ÊǺ²É­ÖÆÒ©Íƶ¯°¢ÃÀÌæÄáÔÚ´óÖлªÇøÓòÍ⿪·¢µÄÓÅÒìÏàÖúͬ°é¡±£¬£¬£¬£¬£¬£¬£¬vic3308×ܲÃÂÀ°®·æ²©Ê¿ÌåÏÖ£¬£¬£¬£¬£¬£¬£¬¡°ÎÒÃÇÆÚ´ýͨ¹ýºÍÒ½¿âÒ©ÒµµÄϸÃÜÏàÖúÒÔÔ츣ȫÇòµÄ·Î°©»¼Õß¡±¡£¡£¡£¡£¡£¡£

¡°ÎÒÃǺÜÐË·ÜÄܹ»½«°¢ÃÀÌæÄáÄÉÈë×Ô¼ºµÄÁ¢ÒìÒ©ÎïÑз¢¹ÜÏß¡±£¬£¬£¬£¬£¬£¬£¬Ò½¿âÒ©Òµ¶­Ê³¤¡¢Ê×´´È˼æÊ×ϯִÐйÙAlexis Borisy˵£¬£¬£¬£¬£¬£¬£¬¡°±¾´ÎÏàÖúΪ·Î°©ÖÎÁÆÁìÓòÌṩÁËÒ»¸ö¸ßÖÊÁ¿¡¢ÁÙ´²Ð§¹ûÏÔÖøµÄÖÎÁƼƻ®£¬£¬£¬£¬£¬£¬£¬Í¬Ê±Ò²ÈÃÒ½¿âÒ©ÒµÏòןø»¼ÕßÌṩ¿É¼ç¸ºµÄÒªº¦Ò©ÎïÕâһĿµÄ¸ü½üÁËÒ»²½¡±¡£¡£¡£¡£¡£¡£

2020Äê3ÔÂ£¬£¬£¬£¬£¬£¬£¬°¢ÃÀÌæÄá»ñµÃNMPAÅú×¼ÉÏÊÐ£¬£¬£¬£¬£¬£¬£¬ÓÃÓÚEGFR T790MÍ»±äµÄNSCLC»¼ÕߵĶþÏßÖÎÁÆ¡£¡£¡£¡£¡£¡£°¢ÃÀÌæÄáΪÍíÆÚNSCLC»¼ÕßÌṩÁËÒ»ÖÖ¸ßÓÐÓÃÐÔÇÒ¾ßÓÐÓÅÒìÇå¾²ÐÔµÄÖÎÁƼƻ®¡£¡£¡£¡£¡£¡£

ÓйطÇСϸ°û·Î°©

·Î°©ÊÇÈ«ÇòÒÔ¼°Öйúµ¼Ö°©Ö¢»¼ÕßéæÃüµÄ×îÖ÷ÒªÒòËØ¡£¡£¡£¡£¡£¡£2018Äê£¬£¬£¬£¬£¬£¬£¬ÖйúÔ¼ÓÐ867,500ÃûÐÂÕï·Î°©»¼Õß£¬£¬£¬£¬£¬£¬£¬ÆäÖÐ737,400ÃûΪ·ÇСϸ°û·Î°©£¬£¬£¬£¬£¬£¬£¬Ô¼Õ¼ÐÂÕﲡÀýµÄ85%£¬£¬£¬£¬£¬£¬£¬ÕâЩ»¼ÕßµÄ5ÄêÉúÑıÈÀý½öÓÐ19.3%¡£¡£¡£¡£¡£¡£·ÇСϸ°û·Î°©»¼ÕßÖÐÔ¼40%ÊÇEGFRÍ»±äÑôÐÔ²¢ÇÒÆäÖÐÔ¼50%µÄ»¼ÕßÔÚ¾­Ò»´ú»ò¶þ´ú±íƤÉú³¤Òò×ÓÊÜÌ壨EGFR£©ÀÒ°±ËἤøÒÖÖƼÁ£¨TKI£©ÖÎÁƺó»á±¬·¢ÓйØT790MµÄÄÍÒ©Í»±ä¡£¡£¡£¡£¡£¡£^[1]

Óйذ¢ÃÀÌæÄá

°¢ÃÀÌæÄáƬ£¨ÖðÈÕÒ»´Î£¬£¬£¬£¬£¬£¬£¬110mg£©ÓÃÓÚ¼ÈÍù¾­EGFR TKIÖÎÁÆʱ»òÖÎÁƺó·ºÆð¼²²¡Ï£Íû£¬£¬£¬£¬£¬£¬£¬²¢ÇÒ¾­NMPAÅú×¼µÄÒªÁì¼ì²âÈ·Èϱ£´æEGFR T790MÍ»±äÑôÐԵľֲ¿ÍíÆÚ»òתÒÆÐÔNSCLC»¼ÕßµÄÖÎÁÆ¡£¡£¡£¡£¡£¡£°¢ÃÀÌæÄáÔÚÁÙ´²Ç°Ñо¿ÖйØÓÚ³£¼ûEGFRÍ»±äÒÔ¼°T790MÄÍÒ©Í»±ä¾ù¾ßÓÐÄÉĦ¶û¼¶¸ßÒÖÖÆ»îÐÔ¡£¡£¡£¡£¡£¡£

Óйغ²É­ÖÆÒ©

º²É­ÖÆÒ©(3692:HK)ÊÇÑÇÖÞÁìÏȵÄÉúÎïÖÆÒ©¹«Ë¾£¬£¬£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚ¹Ø×¢Öª×ãÁÙ´²Î´¾¹µÄÒ½ÁÆÐèÇó£¬£¬£¬£¬£¬£¬£¬Ò»Á¬Ò»Ö±µØÍƳö¸ü¶àµÄÁ¢Òì²úÆ·£¬£¬£¬£¬£¬£¬£¬¸ÄÉÆÈËÀàµÄ¿µ½¡ºÍÉúÃüÖÊÁ¿¡£¡£¡£¡£¡£¡£º²É­ÖÆÒ©ÏÖÔÚÔÚÖÐÃÀÓµÓÐÁè¼Ý9000ÃûÔ±¹¤¡£¡£¡£¡£¡£¡£

¹«Ë¾½¨ÉèÓÚ1995Äê£¬£¬£¬£¬£¬£¬£¬¾ßÓÐ׿ԽµÄÑз¢ÊµÁ¦ÓëÁè¼Ý20ÄêµÄÑз¢¡¢Éú²úºÍ²úÆ·ÉÌÒµ»¯ÂÄÀú£¬£¬£¬£¬£¬£¬£¬ÔÚÖÐÊàÉñ¾­ÏµÍ³¡¢¿¹Ö×Áö¡¢¿¹Ñ¬È¾¡¢ÌÇÄò²¡¡¢Ïû»¯µÀºÍÐÄѪ¹ÜµÈÁù´óÁìÓò¾ßÓÐÁìÏÈˮƽ¡£¡£¡£¡£¡£¡£¹«Ë¾¾ßÓÐÁè¼Ý1200ÃûÑз¢Ö°Ô±£¬£¬£¬£¬£¬£¬£¬Í¨¹ý×ÔÖ÷Ñз¢£¬£¬£¬£¬£¬£¬£¬ÒѾ­ÀÖ³ÉÉÏÊÐ4¸ö1ÀàÁ¢ÒìÒ©¡£¡£¡£¡£¡£¡£ÂõÁé´ï^?£¨ÂðßøÏõßòÂÈ»¯ÄÆ×¢ÉäÒº£©ÊÇÈ«Çò40ÄêÀ´Ê׸öÏõ»ùßäßòÀ࿹ÑáÑõ¾úÁ¢ÒìÒ©Îï¡£¡£¡£¡£¡£¡£æÚÀ´ÃÀ^?£¨¾ÛÒÒ¶þ´¼ÂåÈûÄÇëÄ×¢ÉäÒº£©ÊÇÎÒ¹úÊ׸ö³¤Ð§GLP-1ÀཱུÌÇÒ©Îï£¬£¬£¬£¬£¬£¬£¬Ò²ÊÇÈ«ÇòµÚÒ»¿îPEG»¯µÄ³¤Ð§½µÌÇÒ©Îï£¬£¬£¬£¬£¬£¬£¬ÁÆЧÃ÷È·£¬£¬£¬£¬£¬£¬£¬Çå¾²ÐÔ¸ßÇÒÿÖܽöÐè×¢ÉäÒ»´Î¡£¡£¡£¡£¡£¡£ºÀɭ꿸£^?£¨¼×»ÇËá·úÂíÌæÄáƬ£©ÊÇÖйúÊ׸ö×ÔÖ÷Ñз¢µÄÐÂÐͶþ´úÂýÐÔËèϵ°×Ѫ²¡ÀࣨCML£©Á¢ÒìÒ©¡£¡£¡£¡£¡£¡£°¢ÃÀÀÖ^?£¨¼×»ÇËá°¢ÃÀÌæÄáƬ£©ÓÃÓÚÖÎÁÆ·ÇСϸ°û·Î°©£¬£¬£¬£¬£¬£¬£¬Îª3´úEGFRÒÖÖƼÁ£¬£¬£¬£¬£¬£¬£¬½â¾öT790MÄÍÒ©ÐÔÄÑÌâ£¬£¬£¬£¬£¬£¬£¬ÑÓÐø»¼ÕßÉúÃü¡£¡£¡£¡£¡£¡£

¹ØÓÚº²É­ÖÆÒ©µÄ¸ü¶àÐÅÏ¢£¬£¬£¬£¬£¬£¬£¬Çë»á¼û£ºwww.hspharm.com

ÓйØÒ½¿âÒ©ÒµEQRx

Ò½¿âÒ©ÒµÖÂÁ¦ÓÚ½µµÍÁ¢ÒìÒ©Îï¼ÛÇ®£¬£¬£¬£¬£¬£¬£¬ÒÔÔ츣»£»£»£»£»£»¼ÕߺÍÈ«Éç»á¡£¡£¡£¡£¡£¡£Í¨¹ýÍŽáÒ½ÁƱ£½¡ÏµÍ³µÄÀûÒæÏà¹ØÕß£¬£¬£¬£¬£¬£¬£¬Ê¹ÓÃ×îÏȽøµÄ¿ÆѧÊÖÒÕ£¬£¬£¬£¬£¬£¬£¬Ò½¿âÒ©Òµ×·ÇóÒÔÔ½·¢¸ßЧºÍ½ÚÔ¼µÄ·½·¨·¢Ã÷¡¢¿ª·¢ºÍÉÏÊиßÖÊÁ¿ÇÒ¾ßÓÐ×ÔÖ÷֪ʶ²úȨµÄÁ¢ÒìÒ©Îï¡£¡£¡£¡£¡£¡£¹«Ë¾×ܲ¿Î»ÓÚÃÀ¹úÂíÈøÖîÈûÖݽ£ÇÅÊÐ£¬£¬£¬£¬£¬£¬£¬ÏÖÔÚÒÑ»ñµÃ°üÀ¨GV, ARCH Venture Partners, Andreessen Horowitz, Casdin Capital, Section 32, NextechºÍArboretum VenturesµÈΣº¦Í¶×Ê»ú¹¹µÄÖ§³Ö¡£¡£¡£¡£¡£¡£

¹ØÓÚÒ½¿âÒ©ÒµµÄ¸ü¶àÐÅÏ¢£¬£¬£¬£¬£¬£¬£¬Çë»á¼û£ºhttps://www.eqrx.com

[1] Frost & Sullivan.

º²É­ÖÆÒ©ÁªÏµ·½·¨£º

Ͷ×ÊÕß¹Øϵ

¶­ËëËë ²©Ê¿

IR@hspharm.com

È«ÇòÉÌÎñÍØÕ¹

Paul Lu ²©Ê¿

partner@hansohbio.com

EQRx ÊÇÒ½¿âÒ©Òµ¹É·ÝÓÐÏÞ¹«Ë¾µÄ×¢²áÉ̱ê¡£¡£¡£¡£¡£¡£